196
Views
19
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood

, , , , &
Pages 223-229 | Received 15 May 2010, Accepted 02 Nov 2010, Published online: 24 Jan 2011

References

  • Perkins SL, Segal GH, Kjeldsberg CR. Classification of non-Hodgkin's lymphomas in children. Semin Diagn Pathol 1995;12:303–313.
  • Horibe K, Akiyama Y, Kobayashi M, etal. Treatment outcome of AT-B88 regimen for B-cell non-Hodgkin's lymphoma and surface immunoglobulin-positive acute lymphoblastic leukemia in children. Int J Hematol 1997;66:89–98.
  • Tsurusawa M, Taga T, Horikoshi Y, etal. Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group. Leuk Lymphoma 2008;49:734–739.
  • Nakagawa A, Nakamura S, Nakamine H, etal. Pathology review for paediatric non-Hodgkin's lymphoma patients in Japan: a report from the Japan association of childhood leukaemia study (JACLS). Eur J Cancer 2004;40:725–733.
  • Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphoma in adults. Semin Oncol 1980;7:332–339.
  • Mori M, Kitamura K, Masuda M, etal. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. Int J Hematol 2005;81:246–254.
  • Gerrard M, Cairo MS, Weston C, etal. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Br J Haematol 2008;141:840–847.
  • Patte C, Auperin A, Gerrard M, etal. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 2007;109:2773–2780.
  • Kikuchi A, Mori T, Fujimoto J, etal. Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol. Leuk Lymphoma 2008;49:757–762.
  • Woessmann W, Seidermann K, Mann G, etal. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005;105:948–958.
  • Cairo MS, Gerrard M, Sposto R, etal. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 2007;109:2736–2743.
  • Sandlund JT, Downing JR, Crist WM, etal. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334:1238–1248.
  • Reiter A. Diagnosis and treatment of childhood non-Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2007:285–296.
  • Patte C, Auperin A, Michon J, etal. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97:3370–3379.
  • Reiter A, Schrappe M, Tiemann M, etal. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster group trial NHL-BFM 90. Blood 1999;94:3294–3306.
  • Cairo MS, Krailo MD, Morse M, etal. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (‘Orange’) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a Children's Cancer Group Report. Leukemia 2002;16:594–600.
  • Gururangan S, Sposto R, Cairo MS, Meadows AT, Finlay JL. Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children's Cancer Group study. J Clin Oncol 2000;18:2017–2025.
  • Sandlund JT, Murphy SB, Santana VM, etal. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma. J Clin Oncol 2000;18:3018–3024.
  • Atra A, Gerrard M, Hobson R, Imeson JD, Hann IM, Pinkerton CR. Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. Br J Hematol 2001;112:965–968.
  • Attarbaschi A, Dworzak M, Steiner M, etal. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer 2005;44:70–76.
  • Fujita N, Mori T, Mitsui T, Inada H, Horibe K, Tsurusawa M. The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: a retrospective analysis of enrolled cases in Japan. Pediatr Blood Cancer 2008;51:188–192.
  • Raetz E, Perkins S, Davenport V, Cairo. B large-cell lymphoma in children and adolescents. Cancer Treat Rev 2003;29:91–98.
  • Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008;26:2767–2778.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.